Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a high mortality rate globally. Oral ...
Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3 ...
Sunil Sharma, M.D., MBA, one of the nation’s leading experts in creating anti-cancer drugs, has been named director of ...
Merck (MRK) stock in focus as anti-cancer agent Welireg is approved in the EU for kidney tumor conditions, VHL disease and ...
Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...
Cancer models developed with 3D bioprinting technology allow for rapid evaluation of individual drug responses.
2don MSN
Enhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new ...
News Medical on MSN6d
Dual-target drug may lead to new treatment approach for breast cancer patientsResearchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
The discovery of this hormone paved the way for Ozempic, making the Gila monster an enormously profitable gift to modern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback